TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06928272: Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

Sponsor: Douglas D. Fraser · Phase: PHASE3 · Area: INFECTIOUS_VACCINE · Target Enrollment: 348 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$1,544,676

Rescue Site Savings

+$1,001,952

Unlock Full NCT06928272 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06928272 Rescue Dossier →